<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33067530</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Hepatocytes trap and silence coxsackieviruses, protecting against systemic disease in mice.</ArticleTitle><Pagination><StartPage>580</StartPage><MedlinePgn>580</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-020-01303-7</ELocationID><Abstract><AbstractText>Previous research suggests that hepatocytes catabolize chemical toxins but do not remove microbial agents, which are filtered out by other liver cells (Kupffer cells and endothelial cells). Here we show that, contrary to current understanding, hepatocytes trap and rapidly silence type B coxsackieviruses (CVBs). In genetically wildtype mice, this activity causes hepatocyte damage, which is alleviated in mice carrying a hepatocyte-specific deletion of the coxsackievirus-adenovirus receptor. However, in these mutant mice, there is a dramatic early rise in blood-borne virus, followed by accelerated systemic disease and increased mortality. Thus, wild type hepatocytes act similarly to a sponge for CVBs, protecting against systemic illness at the expense of their own survival. We speculate that hepatocytes may play a similar role in other viral infections as well, thereby explaining why hepatocytes have evolved their remarkable regenerative capacity. Our data also suggest that, in addition to their many other functions, hepatocytes might be considered an integral part of the innate immune system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Taishi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1360-5431</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, The Scripps Research Institute, 10550N. Torrey Pines Rd., La Jolla, CA, 92037, USA. tkimura@scripps.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Claudia T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, The Scripps Research Institute, 10550N. Torrey Pines Rd., La Jolla, CA, 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitton</LastName><ForeName>J Lindsay</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-8218-551X</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, The Scripps Research Institute, 10550N. Torrey Pines Rd., La Jolla, CA, 92037, USA. lwhitton@scripps.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI114615</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AI114615</GrantID><Acronym>AO</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>18POST33960190</GrantID><Acronym>AHA</Acronym><Agency>American Heart Association-American Stroke Association</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062727">Coxsackie and Adenovirus Receptor-Like Membrane Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062727" MajorTopicYN="N">Coxsackie and Adenovirus Receptor-Like Membrane Protein</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060467" MajorTopicYN="Y">Disease Resistance</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014766" MajorTopicYN="N">Viremia</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33067530</ArticleId><ArticleId IdType="pmc">PMC7568585</ArticleId><ArticleId IdType="doi">10.1038/s42003-020-01303-7</ArticleId><ArticleId IdType="pii">10.1038/s42003-020-01303-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brunner KT, Hurez D, Mc CR, Benacerraf B. Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. J. Immunol. 1960;85:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">13805345</ArticleId></ArticleIdList></Reference><Reference><Citation>Mims CA. The response of mice to large intravenous injections of ectromelia virus. II. The growth of virus in the liver. Br. J. Exp. Pathol. 1959;40:543&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2082325</ArticleId><ArticleId IdType="pubmed">14422712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Dailey PJ, Gettie A, Blanchard J, Ho DD. The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys. J. Virol. 2002;76:5271&#x2013;5273. doi: 10.1128/JVI.76.10.5271-5273.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.10.5271-5273.2002</ArticleId><ArticleId IdType="pmc">PMC136155</ArticleId><ArticleId IdType="pubmed">11967341</ArticleId></ArticleIdList></Reference><Reference><Citation>Benacerraf B, Sebestyen MM, Schlossman S. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system. J. Exp. Med. 1959;110:27&#x2013;48. doi: 10.1084/jem.110.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.110.1.27</ArticleId><ArticleId IdType="pmc">PMC2136961</ArticleId><ArticleId IdType="pubmed">13664867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J. Immunol. 1996;157:2514&#x2013;2520.</Citation><ArticleIdList><ArticleId IdType="pubmed">8805652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan LP, et al. Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium. PLOS Pathog. 2011;7:e1002281. doi: 10.1371/journal.ppat.1002281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002281</ArticleId><ArticleId IdType="pmc">PMC3182912</ArticleId><ArticleId IdType="pubmed">21980295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320&#x2013;1323. doi: 10.1126/science.275.5304.1320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5304.1320</ArticleId><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino TA, et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology. 2000;271:99&#x2013;108. doi: 10.1006/viro.2000.0324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0324</ArticleId><ArticleId IdType="pubmed">10814575</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl Acad. Sci. U.S.A. 1997;94:3352&#x2013;3356. doi: 10.1073/pnas.94.7.3352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.7.3352</ArticleId><ArticleId IdType="pmc">PMC20373</ArticleId><ArticleId IdType="pubmed">9096397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard JR, et al. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am. J. Pathol. 1998;153:417&#x2013;428. doi: 10.1016/S0002-9440(10)65585-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65585-X</ArticleId><ArticleId IdType="pmc">PMC1852975</ArticleId><ArticleId IdType="pubmed">9708802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena I, et al. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology. 2000;271:276&#x2013;288. doi: 10.1006/viro.2000.0332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2000.0332</ArticleId><ArticleId IdType="pubmed">10860882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard NL, et al. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe. 2009;6:91&#x2013;98. doi: 10.1016/j.chom.2009.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.05.018</ArticleId><ArticleId IdType="pmc">PMC2761025</ArticleId><ArticleId IdType="pubmed">19616768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J. Am. Coll. Cardiol. 2009;53:1219&#x2013;1226. doi: 10.1016/j.jacc.2008.10.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.10.064</ArticleId><ArticleId IdType="pubmed">19341864</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JY, Wang SM, Chen IC, Yu CK, Liu CC. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor. Pathog. Dis. 2013;68:52&#x2013;60. doi: 10.1111/2049-632X.12044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2049-632X.12044</ArticleId><ArticleId IdType="pubmed">23620416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, et al. Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J. Infect. 1998;37:270&#x2013;273. doi: 10.1016/S0163-4453(98)92076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-4453(98)92076-X</ArticleId><ArticleId IdType="pubmed">9892531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan MH, Klein SW, McPhee J, Harper RG. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 1983;5:1019&#x2013;1032. doi: 10.1093/clinids/5.6.1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/5.6.1019</ArticleId><ArticleId IdType="pubmed">6318288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura T, Flynn CT, Alirezaei M, Sen GC, Whitton JL. Biphasic and cardiomyocyte-specific IFIT activity protects cardiomyocytes from enteroviral infection. PLoS Pathog. 2019;15:e1007674. doi: 10.1371/journal.ppat.1007674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007674</ArticleId><ArticleId IdType="pmc">PMC6453442</ArticleId><ArticleId IdType="pubmed">30958867</ArticleId></ArticleIdList></Reference><Reference><Citation>Koestner W, et al. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice. PLoS Pathog. 2018;14:e1007235. doi: 10.1371/journal.ppat.1007235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007235</ArticleId><ArticleId IdType="pmc">PMC6107283</ArticleId><ArticleId IdType="pubmed">30075026</ArticleId></ArticleIdList></Reference><Reference><Citation>Takehara T, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology. 2004;127:1189&#x2013;1197. doi: 10.1053/j.gastro.2004.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2004.07.019</ArticleId><ArticleId IdType="pubmed">15480996</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane D, et al. Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses. Nat. Microbiol. 2019;4:1096&#x2013;1104. doi: 10.1038/s41564-019-0425-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-019-0425-6</ArticleId><ArticleId IdType="pmc">PMC6588457</ArticleId><ArticleId IdType="pubmed">30988429</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheig R. Evaluation of tests used to screen patients with liver disorders. Prim. Care. 1996;23:551&#x2013;560. doi: 10.1016/S0095-4543(05)70347-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0095-4543(05)70347-X</ArticleId><ArticleId IdType="pubmed">8888344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JP, et al. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J. Virol. 2010;84:254&#x2013;260. doi: 10.1128/JVI.00631-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00631-09</ArticleId><ArticleId IdType="pmc">PMC2798442</ArticleId><ArticleId IdType="pubmed">19846534</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 2015;15:471&#x2013;485. doi: 10.1038/nri3865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3865</ArticleId><ArticleId IdType="pmc">PMC4808588</ArticleId><ArticleId IdType="pubmed">26160613</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity. 2010;33:955&#x2013;966. doi: 10.1016/j.immuni.2010.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.11.020</ArticleId><ArticleId IdType="pmc">PMC3588567</ArticleId><ArticleId IdType="pubmed">21130004</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DH, Hubscher SG. Systemic viral infections and collateral damage in the liver. Am. J. Pathol. 2006;168:1057&#x2013;1059. doi: 10.2353/ajpath.2006.051296.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.051296</ArticleId><ArticleId IdType="pmc">PMC1606546</ArticleId><ArticleId IdType="pubmed">16565481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C., Shi, L. &amp; Wang, F. S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol.10.1016/S2468-1253(20)30057-1 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129165</ArticleId><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau TN, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39:302&#x2013;310. doi: 10.1002/hep.20111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20111</ArticleId><ArticleId IdType="pmc">PMC7165792</ArticleId><ArticleId IdType="pubmed">14767982</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsaad KO, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection&#x2014;clinicopathological and ultrastructural study. Histopathology. 2018;72:516&#x2013;524. doi: 10.1111/his.13379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.13379</ArticleId><ArticleId IdType="pmc">PMC7165512</ArticleId><ArticleId IdType="pubmed">28858401</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60&#x2013;66. doi: 10.1126/science.276.5309.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.276.5309.60</ArticleId><ArticleId IdType="pubmed">9082986</ArticleId></ArticleIdList></Reference><Reference><Citation>Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am. J. Pathol. 1997;151:1273&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858091</ArticleId><ArticleId IdType="pubmed">9358753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim BK, et al. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc. Res. 2006;71:517&#x2013;526. doi: 10.1016/j.cardiores.2006.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.05.016</ArticleId><ArticleId IdType="pubmed">16806133</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkert S, et al. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor. Circulation. 2009;120:2358&#x2013;2366. doi: 10.1161/CIRCULATIONAHA.108.845339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.845339</ArticleId><ArticleId IdType="pubmed">19933937</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher DR, Cerny AM, Finberg RW. The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proc. Natl Acad. Sci. U.S.A. 2005;102:12897&#x2013;12902. doi: 10.1073/pnas.0506211102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506211102</ArticleId><ArticleId IdType="pmc">PMC1200307</ArticleId><ArticleId IdType="pubmed">16123123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JW, et al. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ. Res. 2006;98:923&#x2013;930. doi: 10.1161/01.RES.0000218041.41932.e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000218041.41932.e3</ArticleId><ArticleId IdType="pubmed">16543498</ArticleId></ArticleIdList></Reference><Reference><Citation>Postic C, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 1999;274:305&#x2013;315. doi: 10.1074/jbc.274.1.305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.1.305</ArticleId><ArticleId IdType="pubmed">9867845</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 1993;75:83&#x2013;97. doi: 10.1016/S0092-8674(05)80086-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(05)80086-8</ArticleId><ArticleId IdType="pubmed">8402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher DR, et al. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis. 2005;42:77&#x2013;85. doi: 10.1002/gene.20127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.20127</ArticleId><ArticleId IdType="pubmed">15864812</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner AA, et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J. Cell Sci. 2005;118:3509&#x2013;3521. doi: 10.1242/jcs.02476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02476</ArticleId><ArticleId IdType="pubmed">16079292</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral, F. et al. Purification of hepatocytes and sinusoidal endothelial cells from mouse liver perfusion. J. Vis. Exp.10.3791/56993 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5894826</ArticleId><ArticleId IdType="pubmed">29553556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunziker IP, Cornell CT, Whitton JL. Deletions within the 5&#x2032;UTR of coxsackievirus B3: consequences for virus translation and replication. Virology. 2007;360:120&#x2013;128. doi: 10.1016/j.virol.2006.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.09.041</ArticleId><ArticleId IdType="pmc">PMC2190293</ArticleId><ArticleId IdType="pubmed">17084431</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>